346 related articles for article (PubMed ID: 30036559)
21. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
Todt D; Gisa A; Radonic A; Nitsche A; Behrendt P; Suneetha PV; Pischke S; Bremer B; Brown RJ; Manns MP; Cornberg M; Bock CT; Steinmann E; Wedemeyer H
Gut; 2016 Oct; 65(10):1733-43. PubMed ID: 27222534
[TBL] [Abstract][Full Text] [Related]
22. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.
van de Garde MDB; Pas SD; van Oord GW; Gama L; Choi Y; de Man RA; Boonstra A; Vanwolleghem T
Sci Rep; 2017 Aug; 7(1):8267. PubMed ID: 28811492
[TBL] [Abstract][Full Text] [Related]
23. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
Kamar N; Rostaing L; Abravanel F; Garrouste C; Lhomme S; Esposito L; Basse G; Cointault O; Ribes D; Nogier MB; Alric L; Peron JM; Izopet J
Gastroenterology; 2010 Nov; 139(5):1612-8. PubMed ID: 20708006
[TBL] [Abstract][Full Text] [Related]
24. High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection.
Liang Z; Shu J; He Q; Zhang F; Dai L; Wang L; Lu F; Wang L
Antiviral Res; 2022 Mar; 199():105274. PubMed ID: 35247472
[TBL] [Abstract][Full Text] [Related]
25. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.
Xu L; Zhou X; Peppelenbosch MP; Pan Q
Arch Virol; 2015 Feb; 160(2):435-9. PubMed ID: 25476751
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis E Virus Infects Neurons and Brains.
Zhou X; Huang F; Xu L; Lin Z; de Vrij FMS; Ayo-Martin AC; van der Kroeg M; Zhao M; Yin Y; Wang W; Cao W; Wang Y; Kushner SA; Marie Peron J; Alric L; de Man RA; Jacobs BC; van Eijk JJ; Aronica EMA; Sprengers D; Metselaar HJ; de Zeeuw CI; Dalton HR; Kamar N; Peppelenbosch MP; Pan Q
J Infect Dis; 2017 Apr; 215(8):1197-1206. PubMed ID: 28199701
[TBL] [Abstract][Full Text] [Related]
28. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
29. Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.
Todt D; Walter S; Brown RJ; Steinmann E
Viruses; 2016 Oct; 8(10):. PubMed ID: 27754363
[TBL] [Abstract][Full Text] [Related]
30. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
31. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
32. [Hepatitis E virus].
Izopet J; Lhomme S; Abravanel F; Roque AM; Kamar N
Presse Med; 2015 Mar; 44(3):328-32. PubMed ID: 25650296
[TBL] [Abstract][Full Text] [Related]
33. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin.
Ambrosioni J; Mamin A; Hadengue A; Bernimoulin M; Samii K; Landelle C; Negro F; Kaiser L
Clin Microbiol Infect; 2014 Oct; 20(10):O718-20. PubMed ID: 24476456
[TBL] [Abstract][Full Text] [Related]
34. Silvestrol Inhibits Chikungunya Virus Replication.
Henss L; Scholz T; Grünweller A; Schnierle BS
Viruses; 2018 Oct; 10(11):. PubMed ID: 30380742
[TBL] [Abstract][Full Text] [Related]
35. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
[TBL] [Abstract][Full Text] [Related]
36. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection.
van de Garde MD; Pas SD; van der Net G; de Man RA; Osterhaus AD; Haagmans BL; Boonstra A; Vanwolleghem T
J Virol; 2016 May; 90(9):4394-401. PubMed ID: 26889028
[TBL] [Abstract][Full Text] [Related]
38. A rat model for hepatitis E virus.
Debing Y; Mishra N; Verbeken E; Ramaekers K; Dallmeier K; Neyts J
Dis Model Mech; 2016 Oct; 9(10):1203-1210. PubMed ID: 27483350
[TBL] [Abstract][Full Text] [Related]
39. Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90.
Nimgaonkar I; Archer NF; Becher I; Shahrad M; LeDesma RA; Mateus A; Caballero-Gómez J; Berneshawi AR; Ding Q; Douam F; Gaska JM; Savitski MM; Kim H; Ploss A
Antiviral Res; 2021 Jan; 185():104997. PubMed ID: 33326835
[TBL] [Abstract][Full Text] [Related]
40. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon.
Debing Y; Emerson SU; Wang Y; Pan Q; Balzarini J; Dallmeier K; Neyts J
Antimicrob Agents Chemother; 2014; 58(1):267-73. PubMed ID: 24145541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
